Autus Pharmaceuticals And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 20.00 K
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -440.49%
- Ebitda -429.68%
- Net Worth -2468.05%
- Total Assets 233.78%
About Autus Pharmaceuticals And Chemicals
Autus Pharmaceuticals And Chemicals Private Limited (APACPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 October 2015 (Nine years and three months 10 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 20.00 K , as per Ministry of Corporate Affairs (MCA) records.
Kapil Kohli and Bahushrut Lugani serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100DL2015PTC286754
-
Company No.
286754
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Oct 2015
-
Date of AGM
28 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Autus Pharmaceuticals And Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kapil Kohli
|
Director | 26-Oct-2015 | Current |
|
Bahushrut Lugani
|
Director | Current |
Financial Performance of Autus Pharmaceuticals And Chemicals.
Autus Pharmaceuticals And Chemicals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 440.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 2468.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Autus Pharmaceuticals And Chemicals?
In 2017, Autus Pharmaceuticals And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vishal Mechanical Works Private LimitedBahushrut Lugani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Autus Pharmaceuticals And Chemicals?
Unlock and access historical data on people associated with Autus Pharmaceuticals And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Autus Pharmaceuticals And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Autus Pharmaceuticals And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.